J P Michiel Sedelaar
Overview
Explore the profile of J P Michiel Sedelaar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
870
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Prive B, Govers T, Israel B, Janssen M, Timmermans B, Peters S, et al.
Eur J Nucl Med Mol Imaging
. 2025 Mar;
PMID: 40072531
Background: Prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) is currently under evaluation for detecting clinically significant prostate cancer. The PSMA-PET/CT may complement the current standard diagnostic pathway for...
2.
Wimper Y, Te Molder L, Sedelaar J, Bomers J, Overduin C, Futterer J
J Vasc Interv Radiol
. 2025 Jan;
PMID: 39884349
Purpose: To investigate the feasibility and safety of MRI-guided focal laser ablation (FLA) in localized, International Society of Urological Pathology (ISUP) grade 1-3, prostate cancer (PCa) using an integrated system....
3.
Vrieling A, Olsson L, Kleuters G, Maurits J, Aben K, Sedelaar J, et al.
Cancer Causes Control
. 2025 Jan;
PMID: 39760894
Purpose: Obesity in mid-life is a well-established risk factor for developing renal cell carcinoma (RCC); however, patients with RCC who are obese at the time of diagnosis have more favorable...
4.
Vrieling A, Maurits J, Gerritsen J, Buffart L, Aben K, Sedelaar J, et al.
Support Care Cancer
. 2024 Nov;
32(12):800.
PMID: 39556130
Purpose: This study examined the associations of device-measured moderate-to-vigorous physical activity (MVPA) and sedentary time as well as self-reported MVPA with health-related quality of life (HRQoL) in patients with localized...
5.
Baas D, Israel B, de Baaij J, Vrijhof H, Hoekstra R, Kusters-Vandevelde H, et al.
World J Urol
. 2024 Oct;
42(1):605.
PMID: 39476127
Objective: To evaluate the effectiveness of extended (e-PLND) and super-extended pelvic lymph node dissection (se-PLND) during robot-assisted radical prostatectomy (RARP) by examining lymph node (LN) yield, complications, LN metastasis, and...
6.
Prive B, Muselaers C, van Oort I, Janssen M, Peters S, van Gemert W, et al.
Front Nucl Med
. 2024 Oct;
2:863101.
PMID: 39354959
Lu-PSMA-617 radioligand therapy is a novel treatment for end-stage prostate cancer, which could also be applied to patients with hormone-sensitive prostate cancer with high expression levels of prostate-specific membrane antigen...
7.
Prive B, Israel B, Janssen M, van der Leest M, de Rooij M, van Ipenburg J, et al.
Radiology
. 2024 May;
311(2):e231879.
PMID: 38771185
Background Multiparametric MRI (mpMRI) is effective for detecting prostate cancer (PCa); however, there is a high rate of equivocal Prostate Imaging Reporting and Data System (PI-RADS) 3 lesions and false-positive...
8.
P van Valenberg F, van der Heijden A, Cutie C, Bhanvadia S, Keegan K, Hampras S, et al.
Eur Urol Open Sci
. 2024 Apr;
62:8-15.
PMID: 38585206
Background And Objective: Patients with intermediate-risk non-muscle-invasive bladder cancer (IR NMIBC) have a high risk of recurrence and need effective therapies to reduce the risk of disease recurrence or progression....
9.
Baas D, de Baaij J, Sedelaar J, Hoekstra R, Vrijhof H, Somford D, et al.
J Robot Surg
. 2024 Mar;
18(1):140.
PMID: 38554195
The aim of this study is to evaluate the major postoperative complication rate after robot-assisted radical prostatectomy (RARP) and to identify related risk factors. A consecutive series of patients who...
10.
Schilham M, Somford D, Kusters-Vandevelde H, Hermsen R, van Basten J, Hoekstra R, et al.
J Nucl Med
. 2024 Jan;
65(3):423-429.
PMID: 38176721
Prostate-specific membrane antigen (PSMA)-targeted radioguided surgery (RGS) aims to optimize the peroperative detection and removal of PSMA-avid lymph node (LN) metastases (LNMs) and has been described in patients with recurrent...